BioLife Solutions (NASDAQ: BLFS) reported Q2 EPS of $0.91, $0.88 better than the analyst estimate of $0.03. Revenue for the quarter came in at $28.5 million versus the consensus estimate of $27.51 million.

For earnings history and earnings-related data on BioLife Solutions (BLFS) click here.